866-997-4948(US-Canada Toll Free)

Europe Kidney Cancer Drug Market Report 2016

Published By :

QYResearch

Published Date : Sep 2016

Category :

Cancer

No. of Pages : 123 Pages

Notes:

Sales, means the sales volume of Kidney Cancer Drug

Revenue, means the sales value of Kidney Cancer Drug



This report studies sales (consumption) of Kidney Cancer Drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Bayer

F. Hoffmann-La Roche

GlaxoSmithKline

Novartis

Pfizer

Abbott Laboratories

Active Biotech

Amgen

Argos Therapeutics

ArQule

AVEO Pharmaceuticals

Bionomics

Bristol-Myers Squibb

Cerulean Pharma

Exelixis

Genentech

immatics biotechnologies

Immunicum

Ono Pharmaceutical

Onyx Therapeutics

Oxford BioMedica

Prometheus Laboratories

Seattle Genetics

Taiwan Liposome

TRACON Pharmaceuticals

Wilex



Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Kidney Cancer Drug in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux



Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by application, this report focuses on sales, market share and growth rate of Kidney Cancer Drug in each application, can be divided into

Application 1

Application 2

Application 3



Table of Contents



Europe Kidney Cancer Drug Market Report 2016

1 Kidney Cancer Drug Overview

1.1 Product Overview and Scope of Kidney Cancer Drug

1.2 Classification of Kidney Cancer Drug

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Kidney Cancer Drug

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Kidney Cancer Drug Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Kidney Cancer Drug (2011-2021)

1.5.1 Europe Kidney Cancer Drug Sales and Growth Rate (2011-2021)

1.5.2 Europe Kidney Cancer Drug Revenue and Growth Rate (2011-2021)



2 Europe Kidney Cancer Drug by Manufacturers, Type and Application

2.1 Europe Kidney Cancer Drug Market Competition by Manufacturers

2.1.1 Europe Kidney Cancer Drug Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Kidney Cancer Drug Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Kidney Cancer Drug (Volume and Value) by Type

2.2.1 Europe Kidney Cancer Drug Sales and Market Share by Type (2011-2016)

2.2.2 Europe Kidney Cancer Drug Revenue and Market Share by Type (2011-2016)

2.3 Europe Kidney Cancer Drug (Volume and Value) by Countries

2.3.1 Europe Kidney Cancer Drug Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Kidney Cancer Drug Revenue and Market Share by Countries (2011-2016)

2.4 Europe Kidney Cancer Drug (Volume) by Application



3 Germany Kidney Cancer Drug (Volume, Value and Sales Price)

3.1 Germany Kidney Cancer Drug Sales and Value (2011-2016)

3.1.1 Germany Kidney Cancer Drug Sales and Growth Rate (2011-2016)

3.1.2 Germany Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

3.1.3 Germany Kidney Cancer Drug Sales Price Trend (2011-2016)

3.2 Germany Kidney Cancer Drug Sales and Market Share by Manufacturers

3.3 Germany Kidney Cancer Drug Sales and Market Share by Type

3.4 Germany Kidney Cancer Drug Sales and Market Share by Application



4 France Kidney Cancer Drug (Volume, Value and Sales Price)

4.1 France Kidney Cancer Drug Sales and Value (2011-2016)

4.1.1 France Kidney Cancer Drug Sales and Growth Rate (2011-2016)

4.1.2 France Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

4.1.4 France Kidney Cancer Drug Sales Price Trend (2011-2016)

4.2 France Kidney Cancer Drug Sales and Market Share by Manufacturers

4.3 France Kidney Cancer Drug Sales and Market Share by Type

4.4 France Kidney Cancer Drug Sales and Market Share by Application



5 UK Kidney Cancer Drug (Volume, Value and Sales Price)

5.1 UK Kidney Cancer Drug Sales and Value (2011-2016)

5.1.1 UK Kidney Cancer Drug Sales and Growth Rate (2011-2016)

5.1.2 UK Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

5.1.5 UK Kidney Cancer Drug Sales Price Trend (2011-2016)

5.2 UK Kidney Cancer Drug Sales and Market Share by Manufacturers

5.3 UK Kidney Cancer Drug Sales and Market Share by Type

5.4 UK Kidney Cancer Drug Sales and Market Share by Application



6 Russia Kidney Cancer Drug (Volume, Value and Sales Price)

6.1 Russia Kidney Cancer Drug Sales and Value (2011-2016)

6.1.1 Russia Kidney Cancer Drug Sales and Growth Rate (2011-2016)

6.1.2 Russia Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

6.1.6 Russia Kidney Cancer Drug Sales Price Trend (2011-2016)

6.2 Russia Kidney Cancer Drug Sales and Market Share by Manufacturers

6.3 Russia Kidney Cancer Drug Sales and Market Share by Type

6.4 Russia Kidney Cancer Drug Sales and Market Share by Application



7 Italy Kidney Cancer Drug (Volume, Value and Sales Price)

7.1 Italy Kidney Cancer Drug Sales and Value (2011-2016)

7.1.1 Italy Kidney Cancer Drug Sales and Growth Rate (2011-2016)

7.1.2 Italy Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

7.1.7 Italy Kidney Cancer Drug Sales Price Trend (2011-2016)

7.2 Italy Kidney Cancer Drug Sales and Market Share by Manufacturers

7.3 Italy Kidney Cancer Drug Sales and Market Share by Type

7.4 Italy Kidney Cancer Drug Sales and Market Share by Application



8 Spain Kidney Cancer Drug (Volume, Value and Sales Price)

8.1 Spain Kidney Cancer Drug Sales and Value (2011-2016)

8.1.1 Spain Kidney Cancer Drug Sales and Growth Rate (2011-2016)

8.1.2 Spain Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

8.1.8 Spain Kidney Cancer Drug Sales Price Trend (2011-2016)

8.2 Spain Kidney Cancer Drug Sales and Market Share by Manufacturers

8.3 Spain Kidney Cancer Drug Sales and Market Share by Type

8.4 Spain Kidney Cancer Drug Sales and Market Share by Application



9 Benelux Kidney Cancer Drug (Volume, Value and Sales Price)

9.1 Benelux Kidney Cancer Drug Sales and Value (2011-2016)

9.1.1 Benelux Kidney Cancer Drug Sales and Growth Rate (2011-2016)

9.1.2 Benelux Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Kidney Cancer Drug Sales Price Trend (2011-2016)

9.2 Benelux Kidney Cancer Drug Sales and Market Share by Manufacturers

9.3 Benelux Kidney Cancer Drug Sales and Market Share by Type

9.4 Benelux Kidney Cancer Drug Sales and Market Share by Application



10 Europe Kidney Cancer Drug Manufacturers Analysis

10.1 Bayer

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Kidney Cancer Drug Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 Bayer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 F. Hoffmann-La Roche

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Kidney Cancer Drug Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 F. Hoffmann-La Roche Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 GlaxoSmithKline

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Kidney Cancer Drug Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 GlaxoSmithKline Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 Novartis

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Kidney Cancer Drug Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 Novartis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Pfizer

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Kidney Cancer Drug Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 Pfizer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Abbott Laboratories

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Kidney Cancer Drug Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Abbott Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 Active Biotech

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Kidney Cancer Drug Product Type, Application and Specification

10.7.2.1 Type I

10.7.2.2 Type II

10.7.3 Active Biotech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 Amgen

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Kidney Cancer Drug Product Type, Application and Specification

10.8.2.1 Type I

10.8.2.2 Type II

10.8.3 Amgen Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 Argos Therapeutics

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Kidney Cancer Drug Product Type, Application and Specification

10.9.2.1 Type I

10.9.2.2 Type II

10.9.3 Argos Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 ArQule

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Kidney Cancer Drug Product Type, Application and Specification

10.10.2.1 Type I

10.10.2.2 Type II

10.10.3 ArQule Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

10.11 AVEO Pharmaceuticals

10.12 Bionomics

10.13 Bristol-Myers Squibb

10.14 Cerulean Pharma

10.15 Exelixis

10.16 Genentech

10.17 immatics biotechnologies

10.18 Immunicum

10.19 Ono Pharmaceutical

10.20 Onyx Therapeutics

10.21 Oxford BioMedica

10.22 Prometheus Laboratories

10.23 Seattle Genetics

10.24 Taiwan Liposome

10.25 TRACON Pharmaceuticals

10.26 Wilex



11 Kidney Cancer Drug Manufacturing Cost Analysis

11.1 Kidney Cancer Drug Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Kidney Cancer Drug



12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Kidney Cancer Drug Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015

12.4 Downstream Buyers



13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List



14 Europe Kidney Cancer Drug Market Forecast (2016-2021)

14.1 Germany Kidney Cancer Drug Sales Forecast (2016-2021)

14.2 France Kidney Cancer Drug Sales Forecast (2016-2021)

14.3 UK Kidney Cancer Drug Sales Forecast (2016-2021)

14.4 Russia Kidney Cancer Drug Sales Forecast (2016-2021)

14.5 Italy Kidney Cancer Drug Sales Forecast (2016-2021)

14.6 Spain Kidney Cancer Drug Sales Forecast (2016-2021)

14.7 Benelux Kidney Cancer Drug Sales Forecast (2016-2021)

14.8 Europe Kidney Cancer Drug Sales Forecast by Type (2016-2021)

14.9 Europe Kidney Cancer Drug Sales Forecast by Application (2016-2021)



15 Research Findings and Conclusion



16 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer





List of Table

List of Tables and Figures



Figure Picture of Kidney Cancer Drug

Table Classification of Kidney Cancer Drug

Figure Europe Sales Market Share of Kidney Cancer Drug by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of Kidney Cancer Drug

Figure Europe Sales Market Share of Kidney Cancer Drug by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany Kidney Cancer Drug Revenue and Growth Rate (2011-2021)

Figure France Kidney Cancer Drug Revenue and Growth Rate (2011-2021)

Figure UK Kidney Cancer Drug Revenue and Growth Rate (2011-2021)

Figure Russia Kidney Cancer Drug Revenue and Growth Rate (2011-2021)

Figure Italy Kidney Cancer Drug Revenue and Growth Rate (2011-2021)

Figure Spain Kidney Cancer Drug Revenue and Growth Rate (2011-2021)

Figure Benelux Kidney Cancer Drug Revenue and Growth Rate (2011-2021)

Figure Europe Kidney Cancer Drug Sales and Growth Rate (2011-2021)

Figure Europe Kidney Cancer Drug Revenue and Growth Rate (2011-2021)

Table Europe Kidney Cancer Drug Sales of Key Manufacturers (2015 and 2016)

Table Europe Kidney Cancer Drug Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Kidney Cancer Drug Sales Share by Manufacturers

Figure 2016 Kidney Cancer Drug Sales Share by Manufacturers

Table Europe Kidney Cancer Drug Revenue by Manufacturers (2015 and 2016)

Table Europe Kidney Cancer Drug Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Kidney Cancer Drug Revenue Share by Manufacturers

Table 2016 Europe Kidney Cancer Drug Revenue Share by Manufacturers

Table Europe Kidney Cancer Drug Sales and Market Share by Type (2011-2016)

Table Europe Kidney Cancer Drug Sales Share by Type (2011-2016)

Figure Sales Market Share of Kidney Cancer Drug by Type (2011-2016)

Figure Europe Kidney Cancer Drug Sales Growth Rate by Type (2011-2016)

Table Europe Kidney Cancer Drug Revenue and Market Share by Type (2011-2016)

Table Europe Kidney Cancer Drug Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Kidney Cancer Drug by Type (2011-2016)

Figure Europe Kidney Cancer Drug Revenue Growth Rate by Type (2011-2016)

Table Europe Kidney Cancer Drug Sales and Market Share by Countries (2011-2016)

Table Europe Kidney Cancer Drug Sales Share by Countries (2011-2016)

Figure Sales Market Share of Kidney Cancer Drug by Countries (2011-2016)

Table Europe Kidney Cancer Drug Revenue and Market Share by Countries (2011-2016)

Table Europe Kidney Cancer Drug Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Kidney Cancer Drug by Countries (2011-2016)

Table Europe Kidney Cancer Drug Sales and Market Share by Application (2011-2016)

Table Europe Kidney Cancer Drug Sales Share by Application (2011-2016)

Figure Sales Market Share of Kidney Cancer Drug by Application (2011-2016)

Figure Germany Kidney Cancer Drug Sales and Growth Rate (2011-2016)

Figure Germany Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

Figure Germany Kidney Cancer Drug Sales Price Trend (2011-2016)

Table Germany Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)

Table Germany Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)

Table Germany Kidney Cancer Drug Sales by Type (2015 and 2016)

Table Germany Kidney Cancer Drug Market Share by Type (2015 and 2016)

Table Germany Kidney Cancer Drug Sales by Application (2015 and 2016)

Table Germany Kidney Cancer Drug Market Share by Application (2015 and 2016)

Figure France Kidney Cancer Drug Sales and Growth Rate (2011-2016)

Figure France Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

Figure France Kidney Cancer Drug Sales Price Trend (2011-2016)

Table France Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)

Table France Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)

Table France Kidney Cancer Drug Sales by Type (2015 and 2016)

Table France Kidney Cancer Drug Market Share by Type (2015 and 2016)

Table France Kidney Cancer Drug Sales by Application (2015 and 2016)

Table France Kidney Cancer Drug Market Share by Application (2015 and 2016)

Figure UK Kidney Cancer Drug Sales and Growth Rate (2011-2016)

Figure UK Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

Figure UK Kidney Cancer Drug Sales Price Trend (2011-2016)

Table UK Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)

Table UK Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)

Table UK Kidney Cancer Drug Sales by Type (2015 and 2016)

Table UK Kidney Cancer Drug Market Share by Type (2015 and 2016)

Table UK Kidney Cancer Drug Sales by Application (2015 and 2016)

Table UK Kidney Cancer Drug Market Share by Application (2015 and 2016)

Figure Russia Kidney Cancer Drug Sales and Growth Rate (2011-2016)

Figure Russia Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

Figure Russia Kidney Cancer Drug Sales Price Trend (2011-2016)

Table Russia Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)

Table Russia Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)

Table Russia Kidney Cancer Drug Sales by Type (2015 and 2016)

Table Russia Kidney Cancer Drug Market Share by Type (2015 and 2016)

Table Russia Kidney Cancer Drug Sales by Application (2015 and 2016)

Table Russia Kidney Cancer Drug Market Share by Application (2015 and 2016)

Figure Italy Kidney Cancer Drug Sales and Growth Rate (2011-2016)

Figure Italy Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

Figure Italy Kidney Cancer Drug Sales Price Trend (2011-2016)

Table Italy Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)

Table Italy Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)

Table Italy Kidney Cancer Drug Sales by Type (2015 and 2016)

Table Italy Kidney Cancer Drug Market Share by Type (2015 and 2016)

Table Italy Kidney Cancer Drug Sales by Application (2015 and 2016)

Table Italy Kidney Cancer Drug Market Share by Application (2015 and 2016)

Figure Spain Kidney Cancer Drug Sales and Growth Rate (2011-2016)

Figure Spain Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

Figure Spain Kidney Cancer Drug Sales Price Trend (2011-2016)

Table Spain Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)

Table Spain Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)

Table Spain Kidney Cancer Drug Sales by Type (2015 and 2016)

Table Spain Kidney Cancer Drug Market Share by Type (2015 and 2016)

Table Spain Kidney Cancer Drug Sales by Application (2015 and 2016)

Table Spain Kidney Cancer Drug Market Share by Application (2015 and 2016)

Figure Benelux Kidney Cancer Drug Sales and Growth Rate (2011-2016)

Figure Benelux Kidney Cancer Drug Revenue and Growth Rate (2011-2016)

Figure Benelux Kidney Cancer Drug Sales Price Trend (2011-2016)

Table Benelux Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)

Table Benelux Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)

Table Benelux Kidney Cancer Drug Sales by Type (2015 and 2016)

Table Benelux Kidney Cancer Drug Market Share by Type (2015 and 2016)

Table Benelux Kidney Cancer Drug Sales by Application (2015 and 2016)

Table Benelux Kidney Cancer Drug Market Share by Application (2015 and 2016)

Table Kidney Cancer Drug Basic Information List

Table Bayer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bayer Kidney Cancer Drug Sales Market Share (2011-2016)

Table F. Hoffmann-La Roche Basic Information List

Table F. Hoffmann-La Roche Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table F. Hoffmann-La Roche Kidney Cancer Drug Sales Market Share (2011-2016)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Kidney Cancer Drug Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Kidney Cancer Drug Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Kidney Cancer Drug Sales Market Share (2011-2016)

Table Abbott Laboratories Basic Information List

Table Abbott Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Abbott Laboratories Kidney Cancer Drug Sales Market Share (2011-2016)

Table Active Biotech Basic Information List

Table Active Biotech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Active Biotech Kidney Cancer Drug Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Kidney Cancer Drug Sales Market Share (2011-2016)

Table Argos Therapeutics Basic Information List

Table Argos Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Argos Therapeutics Kidney Cancer Drug Sales Market Share (2011-2016)

Table ArQule Basic Information List

Table ArQule Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table ArQule Kidney Cancer Drug Sales Market Share (2011-2016)

Table AVEO Pharmaceuticals Basic Information List

Table AVEO Pharmaceuticals Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table AVEO Pharmaceuticals Kidney Cancer Drug Sales Market Share (2011-2016)

Table Bionomics Basic Information List

Table Bionomics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bionomics Kidney Cancer Drug Sales Market Share (2011-2016)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol-Myers Squibb Kidney Cancer Drug Sales Market Share (2011-2016)

Table Cerulean Pharma Basic Information List

Table Cerulean Pharma Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cerulean Pharma Kidney Cancer Drug Sales Market Share (2011-2016)

Table Exelixis Basic Information List

Table Exelixis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Exelixis Kidney Cancer Drug Sales Market Share (2011-2016)

Table Genentech Basic Information List

Table Genentech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genentech Kidney Cancer Drug Sales Market Share (2011-2016)

Table immatics biotechnologies Basic Information List

Table immatics biotechnologies Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table immatics biotechnologies Kidney Cancer Drug Sales Market Share (2011-2016)

Table Immunicum Basic Information List

Table Immunicum Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Immunicum Kidney Cancer Drug Sales Market Share (2011-2016)

Table Ono Pharmaceutical Basic Information List

Table Ono Pharmaceutical Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ono Pharmaceutical Kidney Cancer Drug Sales Market Share (2011-2016)

Table Onyx Therapeutics Basic Information List

Table Onyx Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Onyx Therapeutics Kidney Cancer Drug Sales Market Share (2011-2016)

Table Oxford BioMedica Basic Information List

Table Oxford BioMedica Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Oxford BioMedica Kidney Cancer Drug Sales Market Share (2011-2016)

Table Prometheus Laboratories Basic Information List

Table Prometheus Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Prometheus Laboratories Kidney Cancer Drug Sales Market Share (2011-2016)

Table Seattle Genetics Basic Information List

Table Seattle Genetics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Seattle Genetics Kidney Cancer Drug Sales Market Share (2011-2016)

Table Taiwan Liposome Basic Information List

Table Taiwan Liposome Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Taiwan Liposome Kidney Cancer Drug Sales Market Share (2011-2016)

Table TRACON Pharmaceuticals Basic Information List

Table TRACON Pharmaceuticals Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table TRACON Pharmaceuticals Kidney Cancer Drug Sales Market Share (2011-2016)

Table Wilex Basic Information List

Table Wilex Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Wilex Kidney Cancer Drug Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Kidney Cancer Drug

Figure Manufacturing Process Analysis of Kidney Cancer Drug

Figure Kidney Cancer Drug Industrial Chain Analysis

Table Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015

Table Major Buyers of Kidney Cancer Drug

Table Distributors/Traders List

Figure Germany Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)

Figure Germany Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)

Figure France Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)

Figure France Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)

Figure UK Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)

Figure UK Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)

Figure Russia Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)

Figure Italy Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)

Figure Spain Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)

Table Europe Kidney Cancer Drug Sales Forecast by Type (2016-2021)

Table Europe Kidney Cancer Drug Sales Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *